Menu

Musli Thyropeutics developes a novel cancer treatment for GBM, brain metastases, and other aggressive cancers.

Musli's Technology

Musli's technology harnesses a recent discovery of an association between cancer and hormones to offer a novel therapeutic approach of thyroxine deprivation. Musli's fixed-dose combination therapy effectively induces hypothyroxinemia with promising preliminary oncological results.